Research Team Offers Recommendations to Improve Personalized Care for Multiple Sclerosis Patients
source: pixabay.com

Research Team Offers Recommendations to Improve Personalized Care for Multiple Sclerosis Patients

A New Working Group A team of healthcare professionals from the Institute for Quality and Efficacy in Health Care, the Drug Commission of the German Medical Association, and the Charité…

Continue Reading Research Team Offers Recommendations to Improve Personalized Care for Multiple Sclerosis Patients
Three Courageous Women With Multiple Sclerosis are Fighting the Disease by Running Marathons.
source: pixabay.com

Three Courageous Women With Multiple Sclerosis are Fighting the Disease by Running Marathons.

According to recent articles in Runner’s World Magazine, having a diagnosis of multiple sclerosis has not stopped Cheryl Hile, Jennifer Lee or Melissa Ossanna. Each woman is fighting the symptoms…

Continue Reading Three Courageous Women With Multiple Sclerosis are Fighting the Disease by Running Marathons.
Study Reveals a Key Difference Between People of Color with Multiple Sclerosis and Whites
source: pixabay.com

Study Reveals a Key Difference Between People of Color with Multiple Sclerosis and Whites

According to a story from Multiple Sclerosis News Today, a recent study has revealed a never-before-seen difference in multiple sclerosis patients of different racial backgrounds. The research found that people…

Continue Reading Study Reveals a Key Difference Between People of Color with Multiple Sclerosis and Whites
This Treatment for Multiple Sclerosis Could be on its Way to Approval in the EU
source: pixabay.com

This Treatment for Multiple Sclerosis Could be on its Way to Approval in the EU

According to a story from finanznachricten.de, the drug company Novartis recently announced that the European Medicine Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive…

Continue Reading This Treatment for Multiple Sclerosis Could be on its Way to Approval in the EU

Study Shows Tysabri Reduces Risk of Cognitive Decline for Pediatric-Onset Multiple Sclerosis Patients

The Gap Tysabri is a therapy that has shown efficacy for reducing disease activity in patients diagnosed with pediatric-onset multiple sclerosis (POMS). Previous investigations have indicated that up to 58%…

Continue Reading Study Shows Tysabri Reduces Risk of Cognitive Decline for Pediatric-Onset Multiple Sclerosis Patients